Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases.
Body JJ, Greipp P, Coleman RE, Facon T, Geurs F, Fermand JP, Harousseau JL, Lipton A, Mariette X, Williams CD, Nakanishi A, Holloway D, Martin SW, Dunstan CR, Bekker PJ. Body JJ, et al. Among authors: holloway d. Cancer. 2003 Feb 1;97(3 Suppl):887-92. doi: 10.1002/cncr.11138. Cancer. 2003. PMID: 12548591 Free article. Clinical Trial.
Denosumab in postmenopausal women with low bone mineral density.
McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, Peacock M, Miller PD, Lederman SN, Chesnut CH, Lain D, Kivitz AJ, Holloway DL, Zhang C, Peterson MC, Bekker PJ; AMG 162 Bone Loss Study Group. McClung MR, et al. Among authors: holloway dl. N Engl J Med. 2006 Feb 23;354(8):821-31. doi: 10.1056/NEJMoa044459. N Engl J Med. 2006. PMID: 16495394 Free article. Clinical Trial.
The effect of a single dose of osteoprotegerin in postmenopausal women.
Bekker PJ, Holloway D, Nakanishi A, Arrighi M, Leese PT, Dunstan CR. Bekker PJ, et al. Among authors: holloway d. J Bone Miner Res. 2001 Feb;16(2):348-60. doi: 10.1359/jbmr.2001.16.2.348. J Bone Miner Res. 2001. PMID: 11204435 Free article. Clinical Trial.
Population PK-PD model for Fc-osteoprotegerin in healthy postmenopausal women.
Zierhut ML, Gastonguay MR, Martin SW, Vicini P, Bekker PJ, Holloway D, Leese PT, Peterson MC. Zierhut ML, et al. Among authors: holloway d. J Pharmacokinet Pharmacodyn. 2008 Aug;35(4):379-99. doi: 10.1007/s10928-008-9093-5. Epub 2008 Jul 17. J Pharmacokinet Pharmacodyn. 2008. PMID: 18633695
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials.
Stohl W, Merrill JT, Looney RJ, Buyon J, Wallace DJ, Weisman MH, Ginzler EM, Cooke B, Holloway D, Kaliyaperumal A, Kuchimanchi KR, Cheah TC, Rasmussen E, Ferbas J, Belouski SS, Tsuji W, Zack DJ. Stohl W, et al. Among authors: holloway d. Arthritis Res Ther. 2015 Aug 20;17(1):215. doi: 10.1186/s13075-015-0741-z. Arthritis Res Ther. 2015. PMID: 26290435 Free PMC article. Clinical Trial.
222 results